Article
Mixed methods implementation research of oral antiviral treatment for COVID-19 in low and middle-income countries: a study protocol
2024-10-27
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Introduction</h4> There is an absence of real-world evidence, especially from low- and middle-income countries (LMICs), on the implementation successes and challenges of COVID-19 test and treat (T&T) programs. In 2022, nirmatrelvir/ritonavir was provided as standard of care for mild to moderate COVID-19 treatment in eight LMICs (Ghana, Kenya, Laos, Malawi, Nigeria, Rwanda, Uganda and Zambia)....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2ac4c838-6484-5a97-ab5f-d1aab087a5da
- DOI
- 10.1101/2024.10.25.24316111
